Peptide Encyclopedia

Our encyclopedia of the most researched peptides. Mechanisms of action, studied benefits and research status for each peptide.

38 Guide

Preclinical only (cell and rodent studies). No published human clinical trial.

5-Amino-1MQ

5-Amino-1-methylquinolinium (commonly supplied as the iodide salt)

286.11 g/mol (iodide salt); 159.21 g/mol (cation) →

Research peptide — not approved as a drug for human use

AOD-9604

Anti-Obesity Drug 9604 (Tyr-hGH 177-191 fragment)

1815.06 g/mol →

Clinical Studies

Argireline

Acetyl Hexapeptide-8

888.96 g/mol →

Active Research

BPC-157

Body Protection Compound-157

1419.53 g/mol →

Investigational. Not approved by the FDA or EMA. Phase 3 clinical development.

Cagrilintide

Cagrilintide (AM833, NNC0174-0833), long-acting acylated human amylin analogue

4409.01 g/mol →

Prescription medicine in some countries (Eastern Europe, Russia and the CIS, parts of Asia). Not approved by the FDA in the United States and no centralized EMA authorization. Not for self-administration.

Cerebrolysin

Low-molecular-weight peptide and free amino acid preparation derived from porcine brain protein (EVER Neuro Pharma)

Not applicable (undefined mixture; peptide fraction below ~10,000 Da) →

For research and educational use only — not approved for human use

Certificate of Analysis (CoA)

Peptide Certificate of Analysis — Quality Control Documentation

Varies by peptide (compare measured vs. theoretical value) →

Preclinical research

CJC-1295

Modified Growth Hormone Releasing Hormone

3367.97 g/mol →

Research peptide — not approved for human use

DSIP

Delta Sleep-Inducing Peptide

848.81 g/mol →

Research Only

Epithalon

Regulatory Tetrapeptide / AEDG

390.35 g/mol →

Clinical Studies

GHK-Cu

Copper Peptide GHK-Cu

403.93 g/mol →

Approved in Japan as a diagnostic agent only. Not approved as a therapy in the United States or Europe. Prohibited in sport at all times.

GHRP-2

Growth Hormone Releasing Peptide-2 (pralmorelin, KP-102, GPA-748)

817.98 g/mol →